70 related articles for article (PubMed ID: 1878702)
21. Acute graft versus host disease due to T lymphocytes recognizing a single HLA-DPB1*0501 mismatch.
Gaschet J; Lim A; Liem L; Vivien R; Hallet MM; Harousseau JL; Even J; Goulmy E; Bonneville M; Milpied N; Vié H
J Clin Invest; 1996 Jul; 98(1):100-7. PubMed ID: 8690780
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the effects of CD3 and CD5 donor T cell depletion on graft-versus-leukemia in a murine model for MHC-matched unrelated-donor transplantation.
Okunewick JP; Kociban DL; Machen LL; Buffo MJ
Bone Marrow Transplant; 1994 Jan; 13(1):11-7. PubMed ID: 7517254
[TBL] [Abstract][Full Text] [Related]
23. Leukemia-associated antigens as target structures for a specific immunotherapy in chronic myeloid leukemia.
Greiner J; Schmitt M
Eur J Haematol; 2008 Jun; 80(6):461-8. PubMed ID: 18284627
[TBL] [Abstract][Full Text] [Related]
24. Distinct T cell populations distinguish chronic myeloid leukaemia cells from lymphocytes in the same individual: a model for separating GVHD from GVL reactions.
Datta AR; Barrett AJ; Jiang YZ; Guimarães A; Mavroudis DA; van Rhee F; Gordon AA; Madrigal A
Bone Marrow Transplant; 1994 Oct; 14(4):517-24. PubMed ID: 7858526
[TBL] [Abstract][Full Text] [Related]
25. Chronic myeloid leukemia cells express tumor-associated antigens eliciting specific CD8+ T-cell responses and are lacking costimulatory molecules.
Schmitt M; Li L; Giannopoulos K; Chen J; Brunner C; Barth T; Schmitt A; Wiesneth M; Döhner K; Döhner H; Greiner J
Exp Hematol; 2006 Dec; 34(12):1709-19. PubMed ID: 17157168
[TBL] [Abstract][Full Text] [Related]
26. Graft rejection and hyperacute graft-versus-host disease in stem cell transplantation from non-inherited maternal-antigen-complementary HLA-mismatched siblings.
Okumura H; Yamaguchi M; Kotani T; Sugimori N; Sugimori C; Ozaki J; Kondo Y; Yamazaki H; Chuhjo T; Takami A; Ueda M; Ohtake S; Nakao S
Eur J Haematol; 2007 Feb; 78(2):157-60. PubMed ID: 17313562
[TBL] [Abstract][Full Text] [Related]
27. Immunotherapy with alloreactive T-cells?
Madrigal AJ; Rusakiewicz S; Dodi AI; Rees R
Hematol J; 2004; 5 Suppl 3():S91-5. PubMed ID: 15190286
[No Abstract] [Full Text] [Related]
28. Italian survey on allogeneic BMT for chronic myeloid leukaemia.
Arcese W; Mandelli F; Papa G; Bacigalupo A; Van Lint MT; Lucarelli G; Galimberti P; Polchi P; Tura S; Bandini G
Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():90-1. PubMed ID: 2697445
[No Abstract] [Full Text] [Related]
29. GVHD pathophysiology: is acute different from chronic?
Toubai T; Sun Y; Reddy P
Best Pract Res Clin Haematol; 2008 Jun; 21(2):101-17. PubMed ID: 18503979
[TBL] [Abstract][Full Text] [Related]
30. In vitro cytokine-primed leukaemia cells induce in vivo T cell responsiveness in chronic myeloid leukaemia.
Lim SH; Coleman S; Bailey-Wood R
Bone Marrow Transplant; 1998 Dec; 22(12):1185-90. PubMed ID: 9894722
[TBL] [Abstract][Full Text] [Related]
31. Alternative BCR/ABL splice variants in Philadelphia chromosome-positive leukemias result in novel tumor-specific fusion proteins that may represent potential targets for immunotherapy approaches.
Volpe G; Cignetti A; Panuzzo C; Kuka M; Vitaggio K; Brancaccio M; Perrone G; Rinaldi M; Prato G; Fava M; Geuna M; Pautasso M; Casnici C; Signori E; Tonon G; Tarone G; Marelli O; Fazio VM; Saglio G
Cancer Res; 2007 Jun; 67(11):5300-7. PubMed ID: 17545610
[TBL] [Abstract][Full Text] [Related]
32. A new approach to the prevention of graft-versus-host disease using XomaZyme-H65 following histo-incompatible partially T-depleted marrow grafts.
Henslee PJ; Byers VS; Jennings CD; Marciniak E; Thompson JS; Macdonald JS; Romond EH; Messino MJ; Scannon PJ
Transplant Proc; 1989 Feb; 21(1 Pt 3):3004-7. PubMed ID: 2650413
[No Abstract] [Full Text] [Related]
33. Bone marrow transplantation for patients with chronic myeloid leukaemia: T-cell depletion with Campath-1 reduces the incidence of graft-versus-host disease but may increase the risk of leukaemic relapse.
Apperley JF; Jones L; Hale G; Waldmann H; Hows J; Rombos Y; Tsatalas C; Marcus RE; Goolden AW; Gordon-Smith EC
Bone Marrow Transplant; 1986 May; 1(1):53-66. PubMed ID: 3332120
[TBL] [Abstract][Full Text] [Related]
34. Graft rejection by a population of primed CDw52- host T cells after in vivo/ex vivo T-depleted bone marrow transplantation.
Bunjes D; Theobald M; Wiesneth M; Schrezenmeier H; Hoffmann T; Hertenstein B; Arnold R; Heimpel H
Bone Marrow Transplant; 1993 Sep; 12(3):209-15. PubMed ID: 8241978
[TBL] [Abstract][Full Text] [Related]
35. Multiple minor histocompatibility antigen-specific cytotoxic T lymphocyte clones can be generated during graft rejection after HLA-identical bone marrow transplantation.
Marijt WA; Kernan NA; Diaz-Barrientos T; Veenhof WF; O'Reilly RJ; Willemze R; Falkenburg JH
Bone Marrow Transplant; 1995 Jul; 16(1):125-32. PubMed ID: 7581111
[TBL] [Abstract][Full Text] [Related]
36. Cytotoxic and proliferative functions of T lymphocyte clones derived very shortly after allogeneic bone marrow transplantation.
Hamann W; Bruserud O; Patel S; Schmidt H; Ehninger G; Pawelec G
Bone Marrow Transplant; 1991 Aug; 8(2):113-8. PubMed ID: 1933051
[TBL] [Abstract][Full Text] [Related]
37. Long-term follow-up after bone marrow transplantation for chronic myelogenous leukemia: factors associated with relapse.
Devergie A; Reiffers J; Vernant JP; Herve P; Guyotat D; Maraninchi D; Rio B; Michallet M; Jouet JP; Milpied N
Bone Marrow Transplant; 1990 Jun; 5(6):379-86. PubMed ID: 2088319
[TBL] [Abstract][Full Text] [Related]
38. Prediction of graft versus host disease by frequency analysis of cytotoxic T cells after unrelated donor bone marrow transplantation.
Kaminski E; Hows J; Man S; Brookes P; Mackinnon S; Hughes T; Avakian O; Goldman JM; Batchelor JR
Transplantation; 1989 Oct; 48(4):608-13. PubMed ID: 2508280
[TBL] [Abstract][Full Text] [Related]
39. Graft-versus-host reaction spares normal stem cells in chronic myelogenous leukemia.
Kolb HJ; Mittermüller J; Holler E; Thalmeier K; Bartram CR
Bone Marrow Transplant; 1996 Mar; 17(3):449-52. PubMed ID: 8704705
[TBL] [Abstract][Full Text] [Related]
40. Multilineage antigen expression and possible autocrine secretion of an interleukin 1 by Ph1-positive leukemic cell line KOPM-28.
Mori T; Hayashi J; Nakazawa S; Sugita K; Okazaki T; Minato K
Keio J Med; 1991 Mar; 40(1):13-8. PubMed ID: 2046206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]